Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich A Walker

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Seminars in Hematology|June 18, 2016
Immunomodulation of rheumatologic disorders with non-biologic disease modifying antirheumtic drugsUlrich A Walker
Journal of HIV Therapy|July 3, 2003
Update on mitochondrial toxicity: where are we now?Ulrich A Walker
The New England Journal of Medicine|October 12, 2017
Trial of Tocilizumab in Giant-Cell ArteritisUlrich A Walker
Current Opinion in HIV and AIDS|April 18, 2009
Antiretroviral therapy-induced liver alterationsUlrich A Walker
Arthritis Research & Therapy|August 12, 2009
More about masitinibUlrich A Walker
The New England Journal of Medicine|July 2, 2004
Acquired and inherited lipodystrophiesUlrich A Walker
Current Opinion in Rheumatology|October 24, 2008
Imaging tools for the clinical assessment of idiopathic inflammatory myositisUlrich A Walker
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Safety and efficacy of biologics directed against TNF-alpha and CD20 in the therapy of vasculitis and systemic lupus erythematosus]Ulrich A Walker, Paul Hasler
Expert Review of Clinical Pharmacology|October 3, 2020
Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategiesBénédict Fallet, Ulrich A Walker
Current Rheumatology Reports|September 20, 2015
Role of MRI in diagnosis and management of idiopathic inflammatory myopathiesBritta Maurer, Ulrich A Walker
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Seminars in Hematology|June 18, 2016
Immunomodulation of rheumatologic disorders with non-biologic disease modifying antirheumtic drugsUlrich A Walker
Journal of HIV Therapy|July 3, 2003
Update on mitochondrial toxicity: where are we now?Ulrich A Walker
The New England Journal of Medicine|October 12, 2017
Trial of Tocilizumab in Giant-Cell ArteritisUlrich A Walker
Current Opinion in HIV and AIDS|April 18, 2009
Antiretroviral therapy-induced liver alterationsUlrich A Walker
Arthritis Research & Therapy|August 12, 2009
More about masitinibUlrich A Walker
The New England Journal of Medicine|July 2, 2004
Acquired and inherited lipodystrophiesUlrich A Walker
Current Opinion in Rheumatology|October 24, 2008
Imaging tools for the clinical assessment of idiopathic inflammatory myositisUlrich A Walker
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Safety and efficacy of biologics directed against TNF-alpha and CD20 in the therapy of vasculitis and systemic lupus erythematosus]Ulrich A Walker, Paul Hasler
Expert Review of Clinical Pharmacology|October 3, 2020
Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategiesBénédict Fallet, Ulrich A Walker
Current Rheumatology Reports|September 20, 2015
Role of MRI in diagnosis and management of idiopathic inflammatory myopathiesBritta Maurer, Ulrich A Walker
Pageof 18